Ethacrynic acid inhibits sphingosylphosphorylcholine-induced keratin 8 phosphorylation and reorganization via transglutaminase-2 inhibition

Biomolecules and Therapeutics

Volumn 21, Issue 5, 2013, Pages 338-342

  Byun, Hyun Jung ^a   Jin Kang, Kyung ^a   Park, Mi Kyung ^a   Lee, Hye Ja ^a   Kang, June Hee ^a   Lee, Eun Ji ^a   Kim, You Ri ^a   Kim, Hyun Ji ^a   Woo Kim, Young ^a   Jung, Kyung Chae ^b   Kim, Soo Youl ^b   Lee, Chang Hoon ^a  

^a Dongguk University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Ethacrynic acid; Invasion; Keratin 8 phosphorylation and reorganization; Migration; Sphingosylphosphorylcholine; Transglutaminase 2

Indexed keywords

CYTOKERATIN 8; ETACRYNIC ACID; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SPHINGOSYLPHOSPHORYLCHOLINE;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL NUCLEUS; CELL STRAIN PANC 1; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PANCREAS CARCINOMA; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN REORGANIZATION; TUMOR INVASION;

EID: 84885034992     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2013.066     Document Type: Article

References (26)

1. Beil, M., Micoulet, A., von Wichert, G., Paschke, S., Walther, P., Om-ary, M. B., Van Veldhoven, P. P., Gern, U., Wolff-Hieber, E., Eg-germann, J., Waltenberger, J., Adler, G., Spatz, J. and Seufferlein, T. (2003) Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat. Cell Biol. 5, 803-811.
2. Bordeleau, F., Bessard, J., Sheng, Y. and Marceau, N. (2008) Keratin contribution to cellular mechanical stress response at focal adhesions as assayed by laser tweezers. Biochem. Cell Biol. 86, 352-359.
3. Busch, T., Armacki, M., Eiseler, T., Joodi, G., Temme, C., Jansen, J., von Wichert, G., Omary, M. B., Spatz, J. and Seufferlein, T. (2012) Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells. J. Cell Sci. 125, 2148-2159.
4. Cheng, C. C., Liu, Y. H., Ho, C. C., Chao, W. T., Pei, R. J., Hsu, Y. H., Yeh, K. T., Ho, L. C., Tsai, M. C. and Lai, Y. S. (2008) The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma. J. Mol. Histol. 39, 209-216.
5. Chhabra, A., Verma, A. and Mehta, K. (2009) Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anti-cancer Res. 29, 1909-1919.
6. Cross, S. E., Jin, Y. S., Rao, J. and Gimzewski, J. K. (2007) Nanome-chanical analysis of cells from cancer patients. Nat. Nanotechnol. 2, 780-783.
7. Han, Y., Englert, J. A., Delude, R. L. and Fink, M. P. (2005) Ethacrynic acid inhibits multiple steps in the NF-kappaB signaling pathway. Shock 23, 45-53.
8. Kim, K. M., Noh, M. S., Kim, S. H., Park, M. K., Lee, H. J., Kim, S. Y. and Lee, C. H. (2010) Ethacrynic acid and citral suppressed the all trans retinoid-induced monocyte chemoattractant protein-1 production in human dermal fi broblasts. Biomol. Ther. 18, 71-76.
9. Kim, S. Y. (2011) Transglutaminase 2: a new paradigm for NF-kappaB involvement in disease. Adv. Enzymol. Relat. Areas Mol. Biol. 78, 161-195.
10. Ku, N. O., Azhar, S. and Omary, M. B. (2002) Keratin 8 phosphoryla-tion by p38 kinase regulates cellular keratin fi lament reorganization: modulation by a keratin 1-like disease causing mutation. J. Biol. Chem. 277, 10775-10782.
11. Lai, T. S., Liu, Y., Tucker, T., Daniel, K. R., Sane, D. C., Toone, E., Burke, J. R., Strittmatter, W. J. and Greenberg, C. S. (2008) Identi-fi cation of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chem. Biol. 15, 969-978.
12. Lee, K. N., Arnold, S. A., Birckbichler, P. J., Patterson, M. K., Jr., Fraij, B. M., Takeuchi, Y. and Carter, H. A. (1993) Site-directed muta-genesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity. Biochim. Biophys. Acta 1202, 1-6.
13. Lee, S. H., Kim, N., Kim, S. J., Song, J., Gong, Y. D. and Kim, S. Y. (2013) Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor. J. Cancer Res. Clin. Oncol. 139, 1279-1294.
14. Li, R. and El-Mallakh, R. S. (2004) Differential response of bipolar and normal control lymphoblastoid cell sodium pump to ethacrynic acid. J. Affect. Disord. 80, 11-17.
15. Mhaouty-Kodja, S. (2004) Ghalpha/tissue transglutaminase 2: an emerging G protein in signal transduction. Biol. Cell 96, 363-367.
16. Park, M. K., Jo, S. H., Lee, H. J., Kang, J. H., Kim, Y. R., Kim, H. J., Lee, E. J., Koh, J. Y., Ahn, K. O., Jung, K. C., Oh, S. H., Kim, S. Y. and Lee, C. H. (2013a) Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells. Life Sci. 92, 154-160.
17. Park, M. K., Lee, H. J., Shin, J., Noh, M., Kim, S. Y. and Lee, C. H. (2011) Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells. Biochim. Biophys. Acta 1811, 1021-1029.
18. Park, M. K., Park, Y., Shim, J., Lee, H. J., Kim, S. and Lee, C. H. (2012) Novel involvement of leukotriene B(4) receptor 2 through ERK activation by PP2A down-regulation in leukotriene B(4)-induced keratin phosphorylation and reorganization of pancreatic cancer cells. Biochim. Biophys. Acta 1823, 2120-2129.
19. Park, M. K., You, H. J., Lee, H. J., Kang, J. H., Oh, S. H., Kim, S. Y. and Lee, C. H. (2013b) Transglutaminase-2 induces N-cadherin expression in TGF-beta1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation. Eur. J. Cancer 49, 1692-1705.
20. Rolli, C. G., Seufferlein, T., Kemkemer, R. and Spatz, J. P. (2010) Impact of tumor cell cytoskeleton organization on invasiveness and migration: a microchannel-based approach. PLoS One 5, e8726.
21. Suresh, S. (2007) Biomechanics and biophysics of cancer cells. Acta Biomater. 3, 413-438.
22. Steeg, P. S. (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904.
23. Valastyan, S. and Weinberg, R. A. (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292.
24. Verma, A., Wang, H., Manavathi, B., Fok, J. Y., Mann, A. P., Kumar, R. and Mehta, K. (2006) Increased expression of tissue transglu-taminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res. 66, 10525-10533.
25. Vivas, L. and Chiaraviglio, E. (1989) Central effect of agents which alter sodium transport on water drinking in the rat. Brain Res. Bull. 22, 201-206.
26. Wall, G. C., Bigner, D. and Craig, S. (2003) Ethacrynic acid and the sulfa-sensitive patient. Arch. Intern. Med. 163, 116-117.